BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247-252. [PMID: 21931378 DOI: 10.1038/ajg.2011.314] [Cited by in Crossref: 266] [Cited by in F6Publishing: 242] [Article Influence: 24.2] [Reference Citation Analysis]
Number Citing Articles
1 Mahmud N, Halpern S, Farrell R, Ventura K, Thomasson A, Lewis H, Olthoff KM, Levine MH, Nazarian S, Khungar V. An Advanced Practice Practitioner-Based Program to Reduce 30- and 90-Day Readmissions After Liver Transplantation. Liver Transpl 2019;25:901-10. [PMID: 30947393 DOI: 10.1002/lt.25466] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
2 Patel R, Poddar P, Choksi D, Pandey V, Ingle M, Khairnar H, Sawant P. Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort. Ann Hepatol 2019;18:30-9. [PMID: 31113606 DOI: 10.5604/01.3001.0012.7859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Acharya C, Sehrawat TS, McGuire DB, Shaw J, Fagan A, McGeorge S, Olofson A, White MB, Gavis E, Kamath PS, Bergstrom L, Bajaj JS. Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study. J Med Internet Res 2021;23:e24639. [PMID: 33744844 DOI: 10.2196/24639] [Reference Citation Analysis]
4 Chirapongsathorn S, Talwalkar JA, Kamath PS. Readmission in Cirrhosis: a Growing Problem. Curr Treat Options Gastroenterol. 2016;14:236-246. [PMID: 27037929 DOI: 10.1007/s11938-016-0091-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
5 Ney M, Tangri N, Dobbs B, Bajaj J, Rolfson D, Ma M, Ferguson T, Bhardwaj P, Bailey RJ, Abraldes J, Tandon P. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis. Am J Gastroenterol 2018;113:1506-15. [PMID: 30267028 DOI: 10.1038/s41395-018-0243-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
6 Hu C, Anjur V, Saboo K, Reddy KR, O'leary J, Tandon P, Wong F, Garcia-tsao G, Kamath PS, Lai JC, Biggins SW, Fallon MB, Thuluvath P, Subramanian RM, Maliakkal B, Vargas H, Thacker LR, Iyer RK, Bajaj JS. Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis. Am J Gastroenterol 2021;116:336-46. [DOI: 10.14309/ajg.0000000000000971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Biggins SW, Thuluvath PJ, Fallon MB, Subramanian RM, Vargas H, Thacker LR, O'Leary JG; North American Consortium for the Study of End-Stage Liver Disease. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200-208. [PMID: 26690389 DOI: 10.1002/hep.28414] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 22.0] [Reference Citation Analysis]
8 Seraj SM, Campbell EJ, Argyropoulos SK, Wegermann K, Chung RT, Richter JM. Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy. World J Gastroenterol 2017; 23(37): 6868-6876 [PMID: 29085229 DOI: 10.3748/wjg.v23.i37.6868] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
9 Haque LY, Jakab S, Deng Y, Ciarleglio MM, Tetrault JM. Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis. J Addict Med 2020;14:e337-43. [PMID: 32530887 DOI: 10.1097/ADM.0000000000000677] [Reference Citation Analysis]
10 van Vugt JLA, Buettner S, Alferink LJM, Bossche N, de Bruin RWF, Darwish Murad S, Polak WG, Metselaar HJ, Ijzermans JNM. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transpl Int 2018;31:165-74. [DOI: 10.1111/tri.13048] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
11 Ghaoui R, Friderici J, Visintainer P, Lindenauer PK, Lagu T, Desilets D. Measurement of the quality of care of patients admitted with decompensated cirrhosis. Liver Int. 2014;34:204-210. [PMID: 23763303 DOI: 10.1111/liv.12225] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
12 Duarte-Rojo A, Allampati S, Thacker LR, Flud CR, Patidar KR, White MB, Klair JS, Heuman DM, Wade JB, Gavis EA, Bajaj JS. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing. Metab Brain Dis. 2019;34:289-295. [PMID: 30506333 DOI: 10.1007/s11011-018-0350-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
13 Orman ES, Ghabril M, Emmett TW, Chalasani N. Hospital Readmissions in Patients with Cirrhosis: A Systematic Review. J Hosp Med. 2018;. [PMID: 29694458 DOI: 10.12788/jhm.2967] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
14 Sood KT, Wong RJ. Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients. J Clin Exp Hepatol 2019;9:484-90. [PMID: 31571775 DOI: 10.1016/j.jceh.2019.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 VanWagner LB, Kanwal F. Hepatology in a changing health care landscape: A call for health services research. Hepatology 2018;68:1154-62. [PMID: 29537697 DOI: 10.1002/hep.29880] [Reference Citation Analysis]
16 Morgan MY. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides. Metab Brain Dis 2016;31:1361-4. [PMID: 27638474 DOI: 10.1007/s11011-016-9910-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chirapongsathorn S, Krittanawong C, Enders FT, Pendegraft R, Mara KC, Borah BJ, Visscher SL, Loftus CG, Shah VH, Talwalkar JA, Kamath PS. Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis. Hepatol Commun. 2018;2:188-198. [PMID: 29404526 DOI: 10.1002/hep4.1137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
18 Lone NI, Lee R, Walsh TS. Long-Term Mortality and Hospital Resource Use in ICU Patients With Alcohol-Related Liver Disease. Crit Care Med 2019;47:23-32. [PMID: 30247272 DOI: 10.1097/CCM.0000000000003421] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Rush B, Deol N, Teriyaki A, Sey M, Jairath V, Walley KR, Celi LA, Brahmania M. Lower 90-day Hospital Readmission Rates for Esophageal Variceal Bleeding After TIPS: A Nationwide Linked Analysis. J Clin Gastroenterol 2020;54:90-5. [PMID: 30829905 DOI: 10.1097/MCG.0000000000001199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Poovorawan K, Treeprasertsuk S, Thepsuthammarat K, Wilairatana P, Kitsahawong B, Phaosawasdi K. The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide study. Ann Hepatol 2015;14:862-8. [PMID: 26436358 DOI: 10.5604/16652681.1171773] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
21 Lago-Hernandez C, Nguyen NH, Khera R, Loomba R, Asrani SK, Singh S. Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases. Mayo Clin Proc 2021:S0025-6196(21)00255-X. [PMID: 34120754 DOI: 10.1016/j.mayocp.2021.02.026] [Reference Citation Analysis]
22 Rawson TM, Bouri S, Allen C, Ferreira-Martins J, Yusuf A, Stafford N, Pitcher M, Jacyna M. Improving the management of spontaneous bacterial peritonitis in cirrhotic patients: assessment of an intervention in trainee doctors. Clin Med (Lond) 2015;15:426-30. [PMID: 26430179 DOI: 10.7861/clinmedicine.15-5-426] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Thomson MJ, Lok AS, Tapper EB. Optimizing medication management for patients with cirrhosis: Evidence-based strategies and their outcomes. Liver Int 2018;38:1882-90. [PMID: 29845749 DOI: 10.1111/liv.13892] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
24 Nowak S, Mesropyan N, Faron A, Block W, Reuter M, Attenberger UI, Luetkens JA, Sprinkart AM. Detection of liver cirrhosis in standard T2-weighted MRI using deep transfer learning. Eur Radiol 2021. [PMID: 33974149 DOI: 10.1007/s00330-021-07858-1] [Reference Citation Analysis]
25 Elwir S, Rahimi RS. Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options. J Clin Transl Hepatol. 2017;5:142-151. [PMID: 28660152 DOI: 10.14218/jcth.2016.00069] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
26 Strainiene S, Peciulyte M, Strainys T, Stundiene I, Savlan I, Liakina V, Valantinas J. Management of Flood syndrome: What can we do better? World J Gastroenterol 2021; 27(32): 5297-5305 [PMID: 34539133 DOI: 10.3748/wjg.v27.i32.5297] [Reference Citation Analysis]
27 Ganapathy D, Acharya C, Lachar J, Patidar K, Sterling RK, White MB, Ignudo C, Bommidi S, DeSoto J, Thacker LR, Matherly S, Shaw J, Siddiqui MS, Puri P, Sanyal AJ, Luketic V, Lee H, Stravitz RT, Bajaj JS. The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions. Liver Int. 2017;37:1843-1851. [PMID: 28618192 DOI: 10.1111/liv.13494] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
28 Balbinot P, Leone S, Testino G, Caputo F. Hospital readmission of patients with hepatic encephalopathy: Is the introduction of the formal caregiver useful in care management? Dig Liver Dis 2020;52:358-9. [PMID: 31874833 DOI: 10.1016/j.dld.2019.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
29 Ishikawa T, Aibe Y, Matsuda T, Iwamoto T, Takami T, Sakaida I. Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts. AJR Am J Roentgenol 2017;209:W169-76. [PMID: 28657848 DOI: 10.2214/AJR.16.17307] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
30 Orman ES, Ghabril MS, Desai AP, Nephew L, Patidar KR, Gao S, Xu C, Chalasani N. Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00814-4. [PMID: 34311111 DOI: 10.1016/j.cgh.2021.07.032] [Reference Citation Analysis]
31 Spiewak T, Taefi A, Patel S, Li CS, Chak E. Racial disparities of Black Americans hospitalized for decompensated liver cirrhosis. BMC Gastroenterol. 2020;20:245. [PMID: 32727386 DOI: 10.1186/s12876-020-01392-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Millson C, Considine A, Cramp ME, Holt A, Hubscher S, Hutchinson J, Jones K, Leithead J, Masson S, Menon K, Mirza D, Neuberger J, Prasad R, Pratt A, Prentice W, Shepherd L, Simpson K, Thorburn D, Westbrook R, Tripathi D. Adult liver transplantation: A UK clinical guideline - part 1: pre-operation. Frontline Gastroenterol 2020;11:375-84. [PMID: 32879721 DOI: 10.1136/flgastro-2019-101215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
33 Volk ML. Hospital readmissions for decompensated cirrhosis. Clinical Liver Disease. 2014;4:138-140. [PMID: 30992941 DOI: 10.1002/cld.420] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
34 Bloom PP, Ventoso M, Tapper E, Ha J, Richter JM. A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving. Dig Dis Sci 2021. [PMID: 34018070 DOI: 10.1007/s10620-021-07013-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Mukthinuthalapati VVPK, Akinyeye S, Fricker ZP, Syed M, Orman ES, Nephew L, Vilar-Gomez E, Slaven J, Chalasani N, Balakrishnan M, Long MT, Attar BM, Ghabril M. Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals. PLoS One 2019;14:e0211811. [PMID: 30840670 DOI: 10.1371/journal.pone.0211811] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
36 Ramachandran J, Woodman RJ, Muller KR, Wundke R, McCormick R, Kaambwa B, Wigg AJ. Validation of Knowledge Questionnaire for Patients With Liver Cirrhosis. Clin Gastroenterol Hepatol 2020;18:1867-1873.e1. [PMID: 31809918 DOI: 10.1016/j.cgh.2019.11.045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Jinjuvadia R, Salami A, Lenhart A, Jinjuvadia K, Liangpunsakul S, Salgia R. Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States. Am J Med Sci 2017;354:362-9. [PMID: 29078840 DOI: 10.1016/j.amjms.2017.05.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
38 Berry PA, Thomson SJ, Rahman TM, Ala A. Review article: towards a considered and ethical approach to organ support in critically-ill patients with cirrhosis. Aliment Pharmacol Ther. 2013;37:174-182. [PMID: 23157692 DOI: 10.1111/apt.12133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
39 Lyon KC, Likar E, Martello JL, Regier M. Retrospective cross-sectional pilot study of rifaximin dosing for the prevention of recurrent hepatic encephalopathy. J Gastroenterol Hepatol 2017;32:1548-52. [PMID: 28177545 DOI: 10.1111/jgh.13759] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
40 Chen J, Huang ZB, Fan XG, Hu XW, Qi M, Liao CJ, Long LY, Huang Y. Potential predictors for prognosis and postpartum recovery time of acute fatty liver of pregnancy. BMC Pregnancy Childbirth 2020;20:601. [PMID: 33028240 DOI: 10.1186/s12884-020-03287-y] [Reference Citation Analysis]
41 Aspinall RJ. Reducing recurrent hospital admissions in patients with decompensated cirrhosis. Br J Hosp Med (Lond) 2018;79:93-6. [PMID: 29431486 DOI: 10.12968/hmed.2018.79.2.93] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Pantham G, Post A, Venkat D, Einstadter D, Mullen KD. A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis. Dig Dis Sci 2017;62:2166-73. [DOI: 10.1007/s10620-017-4630-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
43 Johnson KB, Campbell EJ, Chi H, Zheng H, King LY, Wu Y, Delemos A, Hurairah A, Corey K, Richter JM. Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort. Dig Dis Sci. 2014;59:174-182. [PMID: 23990035 DOI: 10.1007/s10620-013-2832-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
44 Bloom PP, Marx M, Wang TJ, Green B, Ha J, Bay C, Chung RT, Richter JM. Attitudes towards digital health tools for outpatient cirrhosis management in patients with decompensated cirrhosis. BMJ Innov 2020;6:18-25. [DOI: 10.1136/bmjinnov-2019-000369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
45 Alavi M, Law MG, Grebely J, Amin J, Hajarizadeh B, George J, Dore GJ. Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study. Journal of Hepatology 2016;65:879-87. [DOI: 10.1016/j.jhep.2016.06.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
46 Fortune B, Cardenas A. Ascites, refractory ascites and hyponatremia in cirrhosis. Gastroenterol Rep (Oxf). 2017;5:104-112. [PMID: 28533908 DOI: 10.1093/gastro/gox010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
47 Tapper EB, Aberasturi D, Zhao Z, Hsu CY, Parikh ND. Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis. Aliment Pharmacol Ther 2020;51:1397-405. [PMID: 32363684 DOI: 10.1111/apt.15749] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
48 Siddique SM, Lane-Fall M, McConnell MJ, Jakhete N, Crismale J, Porges S, Khungar V, Mehta SJ, Goldberg D, Li Z, Schiano T, Regan L, Orloski C, Shea JA. Exploring opportunities to prevent cirrhosis admissions in the emergency department: A multicenter multidisciplinary survey. Hepatol Commun 2018;2:237-44. [PMID: 29507899 DOI: 10.1002/hep4.1141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
49 Rakoski MO, Volk ML. Palliative care and end-stage liver disease: a critical review of current knowledge. Curr Opin Gastroenterol 2019;35:155-60. [PMID: 30925536 DOI: 10.1097/MOG.0000000000000530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
50 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;CD003044. [PMID: 27153247 DOI: 10.1002/14651858.cd003044.pub4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
51 Kc M, Olson APJ, Wang Q, Lim N. Unexpected clinical outcomes following the implementation of a standardised order set for hepatic encephalopathy. BMJ Open Gastroenterol 2021;8:e000621. [PMID: 33866310 DOI: 10.1136/bmjgast-2021-000621] [Reference Citation Analysis]
52 Mellinger JL, Richardson CR, Mathur AK, Volk ML. Variation among United States hospitals in inpatient mortality for cirrhosis. Clin Gastroenterol Hepatol. 2015;13:577-584; quiz e30. [PMID: 25264271 DOI: 10.1016/j.cgh.2014.09.038] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
53 Yazdanyar A, Lo KB, Pelayo J, Sanon J, Romero A, Quintero E, Ahluwalia A, Gupta S, Sankaranarayanan R, Mathew R, Rangaswami J. Association Between Cirrhosis and 30-Day Rehospitalization After Index Hospitalization for Heart Failure. Curr Probl Cardiol 2021;:100993. [PMID: 34571101 DOI: 10.1016/j.cpcardiol.2021.100993] [Reference Citation Analysis]
54 Scaglione SJ, Metcalfe L, Kliethermes S, Vasilyev I, Tsang R, Caines A, Mumtaz S, Goyal V, Khalid A, Shoham D, Markossian T, Luke A, Underwood H, Cotler SJ. Early Hospital Readmissions and Mortality in Patients With Decompensated Cirrhosis Enrolled in a Large National Health Insurance Administrative Database. J Clin Gastroenterol. 2017;51:839-844. [PMID: 28383303 DOI: 10.1097/mcg.0000000000000826] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
55 Meier SK, Shah ND, Talwalkar JA. Adapting the Patient-centered Specialty Practice Model for Populations With Cirrhosis. Clinical Gastroenterology and Hepatology 2016;14:492-6. [DOI: 10.1016/j.cgh.2015.12.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lim N, Sanchez O, Olson A. Impact on 30-d readmissions for cirrhotic patients with ascites after an educational intervention: A pilot study. World J Hepatol 2019; 11(10): 701-709 [PMID: 31749900 DOI: 10.4254/wjh.v11.i10.701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Xu R, Chang J. Progress in treatment of hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2015; 23(11): 1755-1762 [DOI: 10.11569/wcjd.v23.i11.1755] [Reference Citation Analysis]
58 Serper M, Kaplan DE, Shults J, Reese PP, Beste LA, Taddei TH, Werner RM. Quality Measures, All-Cause Mortality, and Health Care Use in a National Cohort of Veterans With Cirrhosis. Hepatology 2019;70:2062-74. [PMID: 31107967 DOI: 10.1002/hep.30779] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
59 Kogiso T, Tokushige K, Hashimoto E, Ikarashi Y, Kodama K, Taniai M, Torii N, Shiratori K. Safety and efficacy of long-term tolvaptan therapy for decompensated liver cirrhosis. Hepatol Res. 2016;46:E194-E200. [PMID: 26123753 DOI: 10.1111/hepr.12547] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
60 Alsahhar JS, Rahimi RS. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy. Current Opinion in Gastroenterology 2019;35:145-54. [DOI: 10.1097/mog.0000000000000527] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
61 Kanwal F, Asch SM, Kramer JR, Cao Y, Asrani S, El-Serag HB. Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis. Hepatology. 2016;64:569-581. [PMID: 26991920 DOI: 10.1002/hep.28558] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
62 Neff G, Zachry W III. Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin. Pharmacoeconomics 2018;36:809-22. [PMID: 29651649 DOI: 10.1007/s40273-018-0641-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
63 Edwards LA, Goldenberg SD, Shawcross DL. Meeting the Challenge of Antimicrobial Resistance in Cirrhosis: The Invisible Threat That Lies Within. Gastroenterology 2021;161:413-5. [PMID: 34048780 DOI: 10.1053/j.gastro.2021.05.043] [Reference Citation Analysis]
64 Saab S, Suraweera D, Au J, Saab EG, Alper TS, Tong MJ. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials. Liver Int. 2016;36:986-993. [PMID: 26561214 DOI: 10.1111/liv.13005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
65 Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M. Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs. Hepat Med. 2015;7:37-42. [PMID: 26203290 DOI: 10.2147/hmer.s87594] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
66 Beck KR, Pantilat SZ, O'Riordan DL, Peters MG. Use of Palliative Care Consultation for Patients with End-Stage Liver Disease: Survey of Liver Transplant Service Providers. J Palliat Med 2016;19:836-41. [PMID: 27092870 DOI: 10.1089/jpm.2016.0002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
67 Zhou H, Della PR, Roberts P, Goh L, Dhaliwal SS. Utility of models to predict 28-day or 30-day unplanned hospital readmissions: an updated systematic review. BMJ Open 2016;6:e011060. [PMID: 27354072 DOI: 10.1136/bmjopen-2016-011060] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 19.3] [Reference Citation Analysis]
68 Patel M, Puangsricharoen P, Arshad HMS, Garrison S, Techasatian W, Ghabril M, Sandrasegaran K, Liangpunsakul S, Tann M. Does providing routine liver volume assessment add value when performing CT surveillance in cirrhotic patients? Abdom Radiol (NY) 2019;44:3263-72. [PMID: 31359098 DOI: 10.1007/s00261-019-02145-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Aye L, Volk ML. Discussion: Hospital readmissions in cirrhosis and the importance of treating alcohol use disorder. Dig Liver Dis 2020;52:788-9. [PMID: 32370934 DOI: 10.1016/j.dld.2020.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Shaheen AA, Nguyen HH, Congly SE, Kaplan GG, Swain MG. Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States. Liver Int. 2019;39:878-884. [PMID: 30688401 DOI: 10.1111/liv.14054] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
71 Dunn MA, Josbeno DA, Tevar AD, Rachakonda V, Ganesh SR, Schmotzer AR, Kallenborn EA, Behari J, Landsittel DP, DiMartini AF, Delitto A. Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization. Am J Gastroenterol 2016;111:1768-75. [PMID: 27575708 DOI: 10.1038/ajg.2016.336] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 12.3] [Reference Citation Analysis]
72 Hatton GB, Ran S, Tranah TH, Shawcross DL. Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis. Curr Hepatology Rep 2020;19:159-67. [DOI: 10.1007/s11901-020-00520-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
73 Mudireddy P, Scott F, Feathers A, Lichtenstein GR. Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions. Inflamm Bowel Dis 2017;23:1832-9. [PMID: 28858068 DOI: 10.1097/MIB.0000000000001242] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
74 Solanki S, Haq KF, Chakinala RC, Khan Z, Aronow WS, Ali Khan M, Siddiqui MT, Haq KS, Frager S, Alimirah M, Nabors C, Samson DJ, Lebovics E, Wolf DC. Inpatient burden of esophageal varices in the United States: analysis of trends in demographics, cost of care, and outcomes. Ann Transl Med 2019;7:480. [PMID: 31700916 DOI: 10.21037/atm.2019.08.34] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
75 Nadim MK, Durand F, Kellum JA, Levitsky J, O’leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent J, Genyk YS. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. Journal of Hepatology 2016;64:717-35. [DOI: 10.1016/j.jhep.2015.10.019] [Cited by in Crossref: 150] [Cited by in F6Publishing: 111] [Article Influence: 25.0] [Reference Citation Analysis]
76 Tapper EB, Jiang ZG, Patwardhan VR. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy. Mayo Clin Proc. 2015;90:646-658. [PMID: 25865476 DOI: 10.1016/j.mayocp.2015.03.003] [Cited by in Crossref: 80] [Cited by in F6Publishing: 60] [Article Influence: 11.4] [Reference Citation Analysis]
77 Lim N, Lidofsky SD. Impact of physician specialty on quality care for patients hospitalized with decompensated cirrhosis. PLoS One. 2015;10:e0123490. [PMID: 25837700 DOI: 10.1371/journal.pone.0123490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
78 Apica BS, Ocama P, Seremba E, Opio KC, Kagimu MM. Decompensated cirrhosis-related admissions in a large urban hospital in Uganda: prevalence, clinical and laboratory features and implications for planning patient management. Afr Health Sci 2013;13:927-32. [PMID: 24940314 DOI: 10.4314/ahs.v13i4.10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
79 Volk ML, Mellinger J, Bansal MB, Gellad ZF, McClellan M, Kanwal F. A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis. Hepatology 2019;69:1300-5. [PMID: 30226642 DOI: 10.1002/hep.30277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
80 Bajaj JS, O'Leary JG, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Lai J, Fallon MB, Thuluvath PJ, Vargas HE, Maliakkal B, Subramanian RM, Thacker LR, Reddy KR. Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort. Aliment Pharmacol Ther 2019;49:1518-27. [PMID: 31032966 DOI: 10.1111/apt.15265] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
81 Ishikawa T, Sasaki R, Nishimura T, Matsuda T, Maeda M, Iwamoto T, Saeki I, Hidaka I, Takami T, Sakaida I. Comparison of patients with hepatic encephalopathy and those with gastric varices before and after balloon-occluded retrograde transvenous obliteration. Hepatol Res 2018;48:1020-30. [PMID: 29882396 DOI: 10.1111/hepr.13199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
82 Madoff DC, Cornman-Homonoff J, Fortune BE, Gaba RC, Lipnik AJ, Yarmohammadi H, Ray CE Jr. Management of Refractory Ascites Due to Portal Hypertension: Current Status. Radiology 2021;298:493-504. [PMID: 33497318 DOI: 10.1148/radiol.2021201960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Fagerström C, Frisman GH. Living With Liver Cirrhosis: A Vulnerable Life. Gastroenterology Nursing 2017;40:38-46. [DOI: 10.1097/sga.0000000000000158] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
84 Hayward KL, Valery PC, Cottrell WN, Irvine KM, Horsfall LU, Tallis CJ, Chachay VS, Ruffin BJ, Martin JH, Powell EE. Prevalence of medication discrepancies in patients with cirrhosis: a pilot study. BMC Gastroenterol. 2016;16:114. [PMID: 27618841 DOI: 10.1186/s12876-016-0530-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
85 Tapper EB, Halbert B, Mellinger J. Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study. Clin Gastroenterol Hepatol. 2016;14:1181-1188.e2. [PMID: 27085758 DOI: 10.1016/j.cgh.2016.04.009] [Cited by in Crossref: 105] [Cited by in F6Publishing: 97] [Article Influence: 17.5] [Reference Citation Analysis]
86 Wei M, Ford J, Li Q, Jeong D, Kwong AJ, Nguyen MH, Chang MS. Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California. Dig Dis Sci 2018;63:2267-74. [PMID: 29457210 DOI: 10.1007/s10620-018-4964-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
87 Yadav D, Lee E, Papachristou GI, O'Connell M. A population-based evaluation of readmissions after first hospitalization for acute pancreatitis. Pancreas 2014;43:630-7. [PMID: 24681876 DOI: 10.1097/MPA.0000000000000078] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
88 Guss D, Sherigar J, Rosen P, Mohanty SR. Diagnosis and Management of Hepatitis C Infection in Primary Care Settings. J Gen Intern Med. 2018;33:551-557. [PMID: 29352420 DOI: 10.1007/s11606-017-4280-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
89 Ebhohon E, Ogundipe OA, Adejumo AC. Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis. Ann Transl Med 2021;9:1608. [PMID: 34926652 DOI: 10.21037/atm-21-5258] [Reference Citation Analysis]
90 Tapper EB, Volk M. Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis. Curr Gastroenterol Rep 2017;19:1. [PMID: 28101791 DOI: 10.1007/s11894-017-0543-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
91 Amblàs-Novellas J, Murray SA, Espaulella J, Martori JC, Oller R, Martinez-Muñoz M, Molist N, Blay C, Gómez-Batiste X. Identifying patients with advanced chronic conditions for a progressive palliative care approach: a cross-sectional study of prognostic indicators related to end-of-life trajectories. BMJ Open 2016;6:e012340. [PMID: 27645556 DOI: 10.1136/bmjopen-2016-012340] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
92 Flamm SL. Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy. Am J Med Sci. 2018;356:296-303. [PMID: 30286824 DOI: 10.1016/j.amjms.2018.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
93 El-Baz FK, Elgohary R, Salama A. Amelioration of Hepatic Encephalopathy Using Dunaliella salina Microalgae in Rats: Modulation of Hyperammonemia/TLR4. Biomed Res Int 2021;2021:8843218. [PMID: 33855084 DOI: 10.1155/2021/8843218] [Reference Citation Analysis]
94 Tsochatzis EA, Bosch J, Burroughs AK. Future treatments of cirrhosis. Expert Rev Gastroenterol Hepatol 2014;8:571-81. [PMID: 24909884 DOI: 10.1586/17474124.2014.902303] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
95 Rogal SS, Winger D, Bielefeldt K, Rollman BL, Szigethy E. Healthcare utilization in chronic liver disease: the importance of pain and prescription opioid use. Liver Int. 2013;33:1497-1503. [PMID: 23758842 DOI: 10.1111/liv.12215] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
96 Rogal SS, Udawatta V, Akpan I, Moghe A, Chidi A, Shetty A, Szigethy E, Bielefeldt K, DiMartini A. Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study. PLoS One 2017;12:e0187176. [PMID: 29149171 DOI: 10.1371/journal.pone.0187176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
97 Hjorth M, Svanberg A, Sjöberg D, Rorsman F, Kaminsky E. Liver cirrhosis turns life into an unpredictable roller coaster: A qualitative interview study. J Clin Nurs 2020;29:4532-43. [PMID: 32888238 DOI: 10.1111/jocn.15478] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Alyahya MS, Hijazi HH, Alshraideh HA, Al-Nasser AD. Using decision trees to explore the association between the length of stay and potentially avoidable readmissions: A retrospective cohort study. Inform Health Soc Care 2017;42:361-77. [PMID: 28084856 DOI: 10.1080/17538157.2016.1269105] [Reference Citation Analysis]
99 Guss D, Sherigar J, Mohanty SR. Missed Diagnosis of Liver Cirrhosis Leads to Disparities in Care for Older Patients. Gastroenterology Res 2018;11:333-9. [PMID: 30344803 DOI: 10.14740/gr1074w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Chirapongsathorn S, Kamath PS. Hospital Readmissions in Decompensated Cirrhosis. Am J Gastroenterol 2015;110:940. [PMID: 26052778 DOI: 10.1038/ajg.2015.142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
101 Hudson B, Round J, Georgeson B, Pring A, Forbes K, Mccune CA, Verne J. Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England. The Lancet Gastroenterology & Hepatology 2018;3:95-103. [DOI: 10.1016/s2468-1253(17)30362-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
102 Grossman Liu L, Rogers JR, Reeder R, Walsh CG, Kansagara D, Vawdrey DK, Salmasian H. Published models that predict hospital readmission: a critical appraisal. BMJ Open 2021;11:e044964. [PMID: 34344671 DOI: 10.1136/bmjopen-2020-044964] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, Fernández J, To U, García-Tsao G, Schnabl B. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers 2016;2:16041. [PMID: 27277335 DOI: 10.1038/nrdp.2016.41] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 26.5] [Reference Citation Analysis]
104 Ho CK, Maselli JH, Terrault NA, Gonzales R. High Rate of Hospital Admissions Among Patients with Cirrhosis Seeking Care in US Emergency Departments. Dig Dis Sci 2015;60:2183-9. [PMID: 25724166 DOI: 10.1007/s10620-015-3594-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
105 Ramachandran J, Smith D, Woodman R, Muller K, Wundke R, McCormick R, Kaambwa B, Wigg A. Psychometric validation of the Partners in Health scale as a self-management tool in patients with liver cirrhosis. Intern Med J 2021;51:2104-10. [PMID: 32833278 DOI: 10.1111/imj.15031] [Reference Citation Analysis]
106 Koola JD, Ho SB, Cao A, Chen G, Perkins AM, Davis SE, Matheny ME. Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis. Dig Dis Sci 2020;65:1003-31. [PMID: 31531817 DOI: 10.1007/s10620-019-05826-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
107 Hirode G, Saab S, Wong RJ. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw Open 2020;3:e201997. [PMID: 32239220 DOI: 10.1001/jamanetworkopen.2020.1997] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
108 Rahimi RS, Rockey DC. Hepatic encephalopathy: how to test and treat. Current Opinion in Gastroenterology 2014;30:265-71. [DOI: 10.1097/mog.0000000000000066] [Cited by in Crossref: 10] [Article Influence: 1.3] [Reference Citation Analysis]
109 Piano S, Morando F, Carretta G, Tonon M, Vettore E, Rosi S, Stanco M, Pilutti C, Romano A, Brocca A, Sticca A, Donato D, Angeli P. Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. Am J Gastroenterol 2017;112:1575-83. [PMID: 28853729 DOI: 10.1038/ajg.2017.253] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
110 Wigg AJ, Chin JK, Muller KR, Ramachandran J, Woodman RJ, Kaambwa B. Cost-effectiveness of a chronic disease management model for cirrhosis: Analysis of a randomized controlled trial. J Gastroenterol Hepatol. 2018;:. [PMID: 29462834 DOI: 10.1111/jgh.14127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Tey KR, Mohan P, Liu X, Desai AP. Closing the Quality Chasm in Cirrhosis. Clin Liver Dis (Hoboken) 2018;12:45-9. [PMID: 30988910 DOI: 10.1002/cld.725] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
112 Hjorth M, Sjöberg D, Svanberg A, Kaminsky E, Langenskiöld S, Rorsman F. Nurse-led clinic for patients with liver cirrhosis-effects on health-related quality of life: study protocol of a pragmatic multicentre randomised controlled trial. BMJ Open 2018;8:e023064. [PMID: 30337316 DOI: 10.1136/bmjopen-2018-023064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
113 Künzler-heule P, Beckmann S, Mahrer-imhof R, Semela D, Händler-schuster D. Being an informal caregiver for a relative with liver cirrhosis and overt hepatic encephalopathy: a phenomenological study. J Clin Nurs 2016;25:2559-68. [DOI: 10.1111/jocn.13298] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
114 Ge PS, Runyon BA. Care coordination for patients with cirrhosis: a "win-win" solution for patients, caregivers, providers, and healthcare expenditures. J Hepatol 2013;59:203-4. [PMID: 23665187 DOI: 10.1016/j.jhep.2013.04.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
115 Kanwal F, Taylor TJ, Kramer JR, Cao Y, Smith D, Gifford AL, El-Serag HB, Naik AD, Asch SM. Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality. JAMA Netw Open 2020;3:e2023780. [PMID: 33141161 DOI: 10.1001/jamanetworkopen.2020.23780] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
116 Yataco M, Cowell A, David W, Keaveny AP, Taner CB, Patel T. Predictors and impacts of hospital readmissions following liver transplantation. Annals of Hepatology 2016;15:356-62. [DOI: 10.5604/16652681.1198805] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
117 Salehi S, Tranah TH, Lim S, Heaton N, Heneghan M, Aluvihare V, Patel VC, Shawcross DL. Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list. Aliment Pharmacol Ther 2019;50:435-41. [PMID: 31169941 DOI: 10.1111/apt.15326] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
118 Volk ML. Hospital Readmission of Patients With Cirrhosis: A Canary in a Coal Mine. Clinical Gastroenterology and Hepatology 2016;14:760-1. [DOI: 10.1016/j.cgh.2015.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
119 Ganesh S, Rogal SS, Yadav D, Humar A, Behari J. Risk factors for frequent readmissions and barriers to transplantation in patients with cirrhosis. PLoS One. 2013;8:e55140. [PMID: 23383085 DOI: 10.1371/journal.pone.0055140] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
120 Morales BP, Planas R, Bartoli R, Morillas RM, Sala M, Casas I, Armengol C, Masnou H. HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis. Dig Liver Dis. 2018;50:76-83. [PMID: 28870446 DOI: 10.1016/j.dld.2017.08.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
121 Scott IA, Shohag H, Ahmed M. Quality of care factors associated with unplanned readmissions of older medical patients: a case-control study. Intern Med J 2014;44:161-70. [PMID: 24320739 DOI: 10.1111/imj.12334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
122 Ufere NN, O'Riordan DL, Bischoff KE, Marks AK, Eneanya N, Chung RT, Jackson V, Pantilat SZ, El-Jawahri A. Outcomes of Palliative Care Consultations for Hospitalized Patients With Liver Disease. J Pain Symptom Manage 2019;58:766-73. [PMID: 31326503 DOI: 10.1016/j.jpainsymman.2019.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
123 Volk ML. Identifying cirrhosis patients for intensive disease management. Dig Dis Sci. 2014;59:22-23. [PMID: 24323181 DOI: 10.1007/s10620-013-2968-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
124 Bittermann T, Hubbard RA, Serper M, Lewis JD, Hohmann SF, VanWagner LB, Goldberg DS. Healthcare utilization after liver transplantation is highly variable among both centers and recipients. Am J Transplant 2018;18:1197-205. [PMID: 29024364 DOI: 10.1111/ajt.14539] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
125 Bloom PP, Robin J, Xu M, Arvind A, Daidone M, Gupta AS, Chung RT. Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment. Am J Gastroenterol 2021;116:1950-3. [PMID: 34465696 DOI: 10.14309/ajg.0000000000001351] [Reference Citation Analysis]
126 Kanwal F, Volk M, Singal A, Angeli P, Talwalkar J. Improving quality of health care for patients with cirrhosis. Gastroenterology. 2014;147:1204-1207. [PMID: 25449026 DOI: 10.1053/j.gastro.2014.10.029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
127 Scarpati G, De Robertis E, Esposito C, Piazza O. Hepatic encephalopathy and cirrhotic cardiomyopathy in Intensive Care Unit. Minerva Anestesiol 2018;84. [DOI: 10.23736/s0375-9393.18.12343-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
128 Rahimi RS, Brown KA, Flamm SL, Brown RS Jr,. Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes. Am J Med 2021:S0002-9343(21)00409-5. [PMID: 34242619 DOI: 10.1016/j.amjmed.2021.06.007] [Reference Citation Analysis]
129 Chirapongsathorn S, Poovorawan K, Soonthornworasiri N, Pan-Ngum W, Phaosawasdi K, Treeprasertsuk S. Thirty-Day Readmission and Cost Analysis in Patients With Cirrhosis: A Nationwide Population-Based Data. Hepatol Commun 2020;4:453-60. [PMID: 32140661 DOI: 10.1002/hep4.1472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Xu X, Tan J, Wang H, Zhao W, Qin B. Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days. Front Med (Lausanne) 2021;8:646875. [PMID: 34136498 DOI: 10.3389/fmed.2021.646875] [Reference Citation Analysis]
131 Volk ML. Burden of Cirrhosis on Patients and Caregivers. Hepatol Commun 2020;4:1107-11. [PMID: 32766471 DOI: 10.1002/hep4.1526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
132 Trieu H, Patel A, Wells C, Saab S, Lee EW. Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy. Dig Dis Sci 2021;66:2595-602. [PMID: 32926262 DOI: 10.1007/s10620-020-06582-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Vorobioff JD, Contreras F, Tanno F, Hernández L, Bessone F, Colombato L, Adi J, Fassio E, Felgueres M, Fernández G, Gaite L, Gibelli D, Darrichon HG, Lafage M, Lombardo D, López S, Mateo A, Mendizábal M, Pecoraro J, Ruf A, Ruiz P, Severini J, Stieben T, Sixto M, Zárate F, Barraza SB, Sierra ID, Pacheco VR, Roblero JP, Rojas JO, González PR, Rodríguez DSM, Sierralta A, Manchego AU, Valdes E, Yaquich P, Wolff R, Valdivia FB, Gallegos RC, Galloso R, Marcelo JS, Montes P, Tenorio L, Veramendi I, Alava E, Armijos X, Benalcazar G, Carrera E, Pazmiño GF, Díaz EM, Garassini M, Marrero RP, Infante M, Suárez DP, Gutiérrez JC, Reyes CMV, Serrano YM, Hernández RH, Martínez OM, González TP, Andara MT, Hernández MS, Gerona S, García I, Tijera F, López EP, Torres K, Garzón M. A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management. Ann Hepatol 2020;19:396-403. [PMID: 32418749 DOI: 10.1016/j.aohep.2020.03.007] [Reference Citation Analysis]
134 Larson AM. Palliative Care for Patients with End-Stage Liver Disease. Curr Gastroenterol Rep 2015;17. [DOI: 10.1007/s11894-015-0440-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
135 Kelly EM, James PD, Murthy S, Antonova L, Wong F, Shaw-Stiffel T, Chalifoux M, Salim M, Tanuseputro P. Health Care Utilization and Costs for Patients With End-Stage Liver Disease Are Significantly Higher at the End of Life Compared to Those of Other Decedents. Clin Gastroenterol Hepatol 2019;17:2339-2346.e1. [PMID: 30743007 DOI: 10.1016/j.cgh.2019.01.046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
136 Kanwal F. Coordinating care in patients with cirrhosis. Clin Gastroenterol Hepatol. 2013;11:859-861. [PMID: 23542329 DOI: 10.1016/j.cgh.2013.03.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
137 Muthiah MD, Sanyal AJ. Burden of Disease due to Nonalcoholic Fatty Liver Disease. Gastroenterol Clin North Am 2020;49:1-23. [PMID: 32033757 DOI: 10.1016/j.gtc.2019.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
138 Gaetano JN, Micic D, Aronsohn A, Reddy G, Te H, Reau NS, Jensen D. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites: The benefit of paracentesis. Journal of Gastroenterology and Hepatology 2016;31:1025-30. [DOI: 10.1111/jgh.13255] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
139 Hsu SJ, Zhang C, Jeong J, Lee SI, McConnell M, Utsumi T, Iwakiri Y. Enhanced Meningeal Lymphatic Drainage Ameliorates Neuroinflammation and Hepatic Encephalopathy in Cirrhotic Rats. Gastroenterology 2021;160:1315-1329.e13. [PMID: 33227282 DOI: 10.1053/j.gastro.2020.11.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
140 Morando F, Maresio G, Piano S, Fasolato S, Cavallin M, Romano A, Rosi S, Gola E, Frigo AC, Stanco M, Destro C, Rupolo G, Mantoan D, Gatta A, Angeli P. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol. 2013;59:257-264. [PMID: 23523582 DOI: 10.1016/j.jhep.2013.03.010] [Cited by in Crossref: 104] [Cited by in F6Publishing: 86] [Article Influence: 11.6] [Reference Citation Analysis]
141 Fagan KJ, Zhao EY, Horsfall LU, Ruffin BJ, Kruger MS, McPhail SM, O'Rourke P, Ballard E, Irvine KM, Powell EE. Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change? Intern Med J. 2014;44:865-872. [PMID: 24893971 DOI: 10.1111/imj.12491] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
142 Chuang CJ, Wu YF, Wu KH, Chen YC. Patients with Liver Cirrhosis as Frequent Attenders of Emergency Departments. Emerg Med Int 2020;2020:8289275. [PMID: 32104605 DOI: 10.1155/2020/8289275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Patidar KR, Thacker LR, Wade JB, White MB, Gavis EA, Fagan A, Sterling RK, Fuchs M, Siddiqui MS, Matherly S, Stravitz RT, Sanyal AJ, Puri P, Luketic VA, Bajaj JS. Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis. Dig Dis Sci 2017;62:1173-9. [PMID: 28258378 DOI: 10.1007/s10620-017-4509-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
144 Bajaj JS, Kakiyama G, Savidge T, Takei H, Kassam ZA, Fagan A, Gavis EA, Pandak WM, Nittono H, Hylemon PB, Boonma P, Haag A, Heuman DM, Fuchs M, John B, Sikaroodi M, Gillevet PM. Antibiotic‐Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant. Hepatology 2018;68:1549-58. [DOI: 10.1002/hep.30037] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 14.5] [Reference Citation Analysis]
145 Qazi Arisar FA, Abid S, Shaikh PA, Awan S. Impact of sepsis and non-communicable diseases on prognostic models to predict the outcome of hospitalized chronic liver disease patients. World J Hepatol 2018; 10(12): 944-955 [PMID: 30631399 DOI: 10.4254/wjh.v10.i12.944] [Reference Citation Analysis]
146 Wigg AJ, McCormick R, Wundke R, Woodman RJ. Efficacy of a chronic disease management model for patients with chronic liver failure. Clin Gastroenterol Hepatol. 2013;11:850-858.e1-4. [PMID: 23375997 DOI: 10.1016/j.cgh.2013.01.014] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 8.3] [Reference Citation Analysis]
147 Alimirah M, Sadiq O, Gordon SC. Novel Therapies in Hepatic Encephalopathy. Clin Liver Dis 2020;24:303-15. [PMID: 32245535 DOI: 10.1016/j.cld.2020.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Axelrod DA, Dzebisashvili N, Lentine K, Segev DL, Dickson R, Tuttle-Newhall E, Freeman R, Schnitzler M. Assessing variation in the costs of care among patients awaiting liver transplantation. Am J Transplant. 2014;14:70-78. [PMID: 24165015 DOI: 10.1111/ajt.12494] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
149 Brahmania M, Wiskar K, Walley KR, Celi LA, Rush B. Lower household income is associated with an increased risk of hospital readmission in patients with decompensated cirrhosis. J Gastroenterol Hepatol 2021;36:1088-94. [PMID: 32562577 DOI: 10.1111/jgh.15153] [Reference Citation Analysis]
150 Ramachandran J, Hossain M, Hrycek C, Tse E, Muller KR, Woodman RJ, Kaambwa B, Wigg AJ. Coordinated care for patients with cirrhosis: fewer liver-related emergency admissions and improved survival. Med J Aust 2018;209:301-5. [PMID: 30257622 DOI: 10.5694/mja17.01164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
151 Tocia C, Dumitru A, Alexandrescu L, Popescu R, Dumitru E. Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis. World J Hepatol 2020; 12(12): 1267-1275 [PMID: 33442453 DOI: 10.4254/wjh.v12.i12.1267] [Reference Citation Analysis]
152 Boudreault S, Chen J, Wu KY, Plüddemann A, Heneghan C. Self-management programmes for cirrhosis: A systematic review. J Clin Nurs 2020;29:3625-37. [PMID: 32671877 DOI: 10.1111/jocn.15416] [Reference Citation Analysis]
153 Jiang TT, Liu XL, Jiang YY, Wang XB, Yang ZY. Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients. Evid Based Complement Alternat Med 2021;2021:6652858. [PMID: 34055016 DOI: 10.1155/2021/6652858] [Reference Citation Analysis]
154 Rao BB, Sobotka A, Lopez R, Romero-Marrero C, Carey W. Outpatient telephonic transitional care after hospital discharge improves survival in cirrhotic patients. World J Hepatol 2019; 11(8): 646-655 [PMID: 31528247 DOI: 10.4254/wjh.v11.i8.646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
155 Mohammed OK, Mahadeva S. Clinical outcomes of cryptogenic compared with non-cryptogenic cirrhosis: A retrospective cohort study. J Gastroenterol Hepatol. 2015;30:1423-1428. [PMID: 25867030 DOI: 10.1111/jgh.12978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
156 Tapper EB. Building Effective Quality Improvement Programs for Liver Disease: A Systematic Review of Quality Improvement Initiatives. Clin Gastroenterol Hepatol 2016;14:1256-1265.e3. [PMID: 27103114 DOI: 10.1016/j.cgh.2016.04.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
157 Laleman W, Simon-Talero M, Maleux G, Perez M, Ameloot K, Soriano G, Villalba J, Garcia-Pagan JC, Barrufet M, Jalan R, Brookes J, Thalassinos E, Burroughs AK, Cordoba J, Nevens F; EASL-CLIF-Consortium. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology. 2013;57:2448-2457. [PMID: 23401201 DOI: 10.1002/hep.26314] [Cited by in Crossref: 143] [Cited by in F6Publishing: 105] [Article Influence: 15.9] [Reference Citation Analysis]
158 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;4:CD003044. [PMID: 27089005 DOI: 10.1002/14651858.cd003044.pub3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
159 Talwalkar JA. Potential impacts of the Affordable Care Act on the clinical practice of hepatology. Hepatology 2014;59:1681-7. [PMID: 24700278 DOI: 10.1002/hep.27071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
160 Mahassadi AK, Nguieguia JLK, Kissi HY, Awuah AA, Bangoura AD, Doffou SA, Attia AK. Systemic inflammatory response syndrome and model for end-stage liver disease score accurately predict the in-hospital mortality of black African patients with decompensated cirrhosis at initial hospitalization: a retrospective cohort study. Clin Exp Gastroenterol 2018;11:143-52. [PMID: 29670387 DOI: 10.2147/CEG.S140655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
161 Langberg KM, Kapo JM, Taddei TH. Palliative care in decompensated cirrhosis: A review. Liver Int 2018;38:768-75. [PMID: 29112338 DOI: 10.1111/liv.13620] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
162 Montagnese S, Bajaj JS. Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues. Drugs 2019;79:11-6. [PMID: 30706419 DOI: 10.1007/s40265-018-1019-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
163 Huang CH, Jeng WJ, Ho YP, Teng W, Hsieh YC, Chen WT, Chen YC, Lin HH, Sheen IS, Lin CY. Increased EMR2 expression on neutrophils correlates with disease severity and predicts overall mortality in cirrhotic patients. Sci Rep 2016;6:38250. [PMID: 27905560 DOI: 10.1038/srep38250] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
164 Asrani SK, Kouznetsova M, Ogola G, Taylor T, Masica A, Pope B, Trotter J, Kamath P, Kanwal F. Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013. Gastroenterology. 2018;155:719-729.e4. [PMID: 29802851 DOI: 10.1053/j.gastro.2018.05.032] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
165 Yi Z, Mayorga ME, Orman ES, Wheeler SB, Hayashi PH, Barritt AS Th. Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration. Transplantation. 2017;101:2368-2374. [PMID: 28858174 DOI: 10.1097/tp.0000000000001851] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
166 Alkhouri N, Singh T, Alsabbagh E, Guirguis J, Chami T, Hanouneh I, Grove D, Lopez R, Dweik R. Isoprene in the Exhaled Breath is a Novel Biomarker for Advanced Fibrosis in Patients with Chronic Liver Disease: A Pilot Study. Clin Transl Gastroenterol 2015;6:e112. [PMID: 26378385 DOI: 10.1038/ctg.2015.40] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
167 Mellinger JL, Volk ML. Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin Gastroenterol Hepatol. 2013;11:217-223. [PMID: 23142204 DOI: 10.1016/j.cgh.2012.10.040] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 6.7] [Reference Citation Analysis]
168 Shen NT, Schneider Y, Congly SE, Rosenblatt RE, Namn Y, Fortune BE, Jesudian A, Brown RS. Cost Effectiveness of Early Insertion of Transjugular Intrahepatic Portosystemic Shunts for Recurrent Ascites. Clin Gastroenterol Hepatol. 2018;16:1503-1510.e3. [PMID: 29609068 DOI: 10.1016/j.cgh.2018.03.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
169 Deitelzweig S, Amin A, Christian R, Friend K, Lin J, Lowe TJ. Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis. Adv Ther 2013;30:71-80. [PMID: 23292659 DOI: 10.1007/s12325-012-0073-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
170 Dahiya M, Eboreime E, Hyde A, Rahman S, Sebastianski M, Carbonneau M, Tapper EB, Tandon P. International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases. Dig Dis Sci 2021. [PMID: 34091800 DOI: 10.1007/s10620-021-07076-1] [Reference Citation Analysis]
171 Muir AJ. Understanding the Complexities of Cirrhosis. Clinical Therapeutics 2015;37:1822-36. [DOI: 10.1016/j.clinthera.2015.05.507] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
172 Rosenblatt R, Cohen-mekelburg S, Shen N, Tafesh Z, Lucero C, Kumar S, Fortune B, Liu SY, Brown R, Jesudian A. Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program. Am J Gastroenterol 2019;114:1488-95. [DOI: 10.14309/ajg.0000000000000257] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
173 Leise MD, Poterucha JJ, Kamath PS, Kim WR. Management of hepatic encephalopathy in the hospital. Mayo Clin Proc 2014;89:241-53. [PMID: 24411831 DOI: 10.1016/j.mayocp.2013.11.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
174 Han B, Wu G, Huang H, Liu T, Wang J, Sun J, Wang H. A semi-packed micro GC column for separation of the NAFLD exhaled breath VOCs. Surface and Coatings Technology 2019;363:322-9. [DOI: 10.1016/j.surfcoat.2019.02.049] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
175 Cheng YW, Sandrasegaran K, Cheng K, Shah A, Ghabril M, Berry W, Lammert C, Chalasani N, Orman ES. A dedicated paracentesis clinic decreases healthcare utilization for serial paracenteses in decompensated cirrhosis. Abdom Radiol (NY) 2018;43:2190-7. [PMID: 29188319 DOI: 10.1007/s00261-017-1406-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
176 Bassegoda O, Huelin P, Ariza X, Solé C, Juanola A, Gratacós-Ginès J, Carol M, Graupera I, Pose E, Napoleone L, Albertos S, de Prada G, Cervera M, Fernández J, Fabrellas N, Poch E, Solà E, Ginès P. Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes. J Hepatol 2020;72:1132-9. [PMID: 31953138 DOI: 10.1016/j.jhep.2019.12.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
177 Sarwar A, Zhou L, Chakrala N, Brook OR, Weinstein JL, Rosen MP, Ahmed M. The Relevance of Readmissions after Common IR Procedures: Readmission Rates and Association with Early Mortality. Journal of Vascular and Interventional Radiology 2017;28:629-36. [DOI: 10.1016/j.jvir.2017.01.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
178 Hayward KL, Weersink RA. Improving Medication-Related Outcomes in Chronic Liver Disease. Hepatol Commun 2020;4:1562-77. [PMID: 33163829 DOI: 10.1002/hep4.1612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Fiati Kenston SS, Song X, Li Z, Zhao J. Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy. J Gastroenterol Hepatol. 2019;34:31-39. [PMID: 30070387 DOI: 10.1111/jgh.14408] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
180 Elsaid MI, John T, Li Y, Pentakota SR, Rustgi VK. The Health Care Burden of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:263-75. [DOI: 10.1016/j.cld.2020.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
181 Desai AP, Reau N. The Burden of Rehospitalization for Patients With Liver Cirrhosis. Hosp Pract (1995) 2016;44:60-9. [PMID: 26782133 DOI: 10.1080/21548331.2016.1142828] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
182 Bajaj JS, Lauridsen M, Tapper EB, Duarte-rojo A, Rahimi RS, Tandon P, Shawcross DL, Thabut D, Dhiman RK, Romero-gomez M, Sharma BC, Montagnese S. Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. Am J Gastroenterol 2020;115:989-1002. [DOI: 10.14309/ajg.0000000000000603] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
183 Wang J, Khan S, Wyer P, Vanderwilp J, Reynolds J, Bethancourt B, Ota KS. The Role of Ultrasound-Guided Therapeutic Paracentesis in an Outpatient Transitional Care Program: A Case Series. Am J Hosp Palliat Care 2018;35:1256-60. [DOI: 10.1177/1049909118755378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Hayward KL, Patel PJ, Valery PC, Horsfall LU, Li CY, Wright PL, Tallis CJ, Stuart KA, Irvine KM, Cottrell WN, Martin JH, Powell EE. Medication-Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention. Hepatol Commun 2019;3:620-31. [PMID: 31061951 DOI: 10.1002/hep4.1334] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
185 Thomson M, Volk M, Kim HM, Piette JD. An Automated Telephone Monitoring System to Identify Patients with Cirrhosis at Risk of Re-hospitalization. Dig Dis Sci 2015;60:3563-9. [DOI: 10.1007/s10620-015-3744-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
186 Volk ML, Kanwal F. Quality of Care in the Cirrhotic Patient. Clin Transl Gastroenterol 2016;7:e166. [PMID: 27101005 DOI: 10.1038/ctg.2016.25] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
187 Kartoun U, Corey KE, Simon TG, Zheng H, Aggarwal R, Ng K, Shaw SY. The MELD-Plus: A generalizable prediction risk score in cirrhosis. PLoS One. 2017;12:e0186301. [PMID: 29069090 DOI: 10.1371/journal.pone.0186301] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
188 Sarwar A, Weinstein JL, Novack V, Chakrala N, Tapper EB, Malik R, Ahmed M. Causes and Rates of 30-Day Readmissions After Transjugular Intrahepatic Portosystemic Shunts. AJR Am J Roentgenol 2020;215:235-41. [PMID: 32374665 DOI: 10.2214/AJR.19.21732] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Møller AD, Christiansen DH, Bell C, Fredberg U, Vedsted P. 24-hour access outpatient clinic for patients with exacerbation of chronic disease: a before-after cohort study of differences in acute healthcare utilisation. BMC Health Serv Res 2018;18:663. [PMID: 30153833 DOI: 10.1186/s12913-018-3475-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
190 Fouad TR, Abdelsameea E, Abdel‐razek W, Attia A, Mohamed A, Metwally K, Naguib M, Waked I. Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators. Journal of Gastroenterology and Hepatology 2019;34:1604-10. [DOI: 10.1111/jgh.14659] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
191 Acharya C, Bajaj JS. Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable Access. Liver Transpl 2021. [PMID: 34018659 DOI: 10.1002/lt.26099] [Reference Citation Analysis]
192 Saab S. Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy. Int J Gen Med. 2015;8:165-173. [PMID: 25999756 DOI: 10.2147/ijgm.s81878] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
193 Singal AG, Rahimi RS, Clark C, Ma Y, Cuthbert JA, Rockey DC, Amarasingham R. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. Clin Gastroenterol Hepatol. 2013;11:1335-1341.e1. [PMID: 23591286 DOI: 10.1016/j.cgh.2013.03.022] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
194 Hayward KL, Martin JH, Cottrell WN, Karmakar A, Horsfall LU, Patel PJ, Smith DD, Irvine KM, Powell EE, Valery PC. Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial. Trials 2017;18:339. [PMID: 28728560 DOI: 10.1186/s13063-017-2075-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
195 Ufere NN, Halford JL, Caldwell J, Jang MY, Bhatt S, Donlan J, Ho J, Jackson V, Chung RT, El-Jawahri A. Health Care Utilization and End-of-Life Care Outcomes for Patients With Decompensated Cirrhosis Based on Transplant Candidacy. J Pain Symptom Manage 2020;59:590-8. [PMID: 31655192 DOI: 10.1016/j.jpainsymman.2019.10.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
196 Bajaj JS, Betrapally NS, Hylemon PB, Thacker LR, Daita K, Kang DJ, White MB, Unser AB, Fagan A, Gavis EA, Sikaroodi M, Dalmet S, Heuman DM, Gillevet PM. Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus. Sci Rep. 2015;5:18559. [PMID: 26692421 DOI: 10.1038/srep18559] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
197 Ginès P, Graupera I, Lammert F, Angeli P, Caballeria L, Krag A, Guha IN, Murad SD, Castera L. Screening for liver fibrosis in the general population: a call for action. The Lancet Gastroenterology & Hepatology 2016;1:256-60. [DOI: 10.1016/s2468-1253(16)30081-4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 19] [Article Influence: 10.2] [Reference Citation Analysis]
198 Talwalkar JA, Oxentenko AS, Katzka DA. Health Care–Delivery Research-Training Opportunities in Gastroenterology and Hepatology. Gastroenterology 2014;146:878-83. [DOI: 10.1053/j.gastro.2014.02.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
199 Frenette CT, Levy C, Saab S. Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door. Dig Dis Sci 2021. [PMID: 34169435 DOI: 10.1007/s10620-021-07075-2] [Reference Citation Analysis]
200 Bajaj JS, Salzman NH, Acharya C, Sterling RK, White MB, Gavis EA, Fagan A, Hayward M, Holtz ML, Matherly S, Lee H, Osman M, Siddiqui MS, Fuchs M, Puri P, Sikaroodi M, Gillevet PM. Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial. Hepatology. 2019;70:1690-1703. [PMID: 31038755 DOI: 10.1002/hep.30690] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 22.7] [Reference Citation Analysis]
201 Zhou XD, Chen QF, Wang ZX, Liu WY, Van Poucke S, Mao Z, Wu SJ, Huang WJ, Zheng MH. Acute circulatory failure-chronic liver failure-sequential organ failure assessment score: a novel scoring model for mortality risk prediction in critically ill cirrhotic patients with acute circulatory failure. Eur J Gastroenterol Hepatol 2017;29:464-71. [PMID: 28030513 DOI: 10.1097/MEG.0000000000000817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
202 Morales BP, Planas R, Bartoli R, Morillas RM, Sala M, Cabré E, Casas I, Masnou H. Early hospital readmission in decompensated cirrhosis: Incidence, impact on mortality, and predictive factors. Dig Liver Dis 2017;49:903-9. [PMID: 28410915 DOI: 10.1016/j.dld.2017.03.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
203 Tapper EB. Challenge accepted: Confronting readmissions for our patients with cirrhosis. Hepatology. 2016;64:26-28. [PMID: 26806609 DOI: 10.1002/hep.28471] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
204 Naik AD, Arney J, Clark JA, Martin LA, Walling AM, Stevenson A, Smith D, Asch SM, Kanwal F. Integrated Model for Patient-Centered Advanced Liver Disease Care. Clinical Gastroenterology and Hepatology 2020;18:1015-24. [DOI: 10.1016/j.cgh.2019.07.043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
205 Elzouki AN, Zahid M, Akbar RA, Alfitori GB, Cherichi Purayil S, Imanullah R, Danjuma MI. Polypharmacy and drug interactions amongst cirrhotic patients discharged from a tertiary center: Results from a national quality improvement audit. Arab J Gastroenterol 2020;21:216-8. [PMID: 33071177 DOI: 10.1016/j.ajg.2020.09.008] [Reference Citation Analysis]
206 Bansal MB. How Hepatologists Can Contribute to Value-Based Care. Clin Gastroenterol Hepatol 2020;18:2153-7. [PMID: 32562890 DOI: 10.1016/j.cgh.2020.06.026] [Reference Citation Analysis]
207 Hernaez R, Kramer JR, Khan A, Phillips J, McCallister K, Chaffin K, Hernandez AP, Fullington H, Ortiz C, Blackwell JM, Loewen A, Liu Y, Tiro JA, Lee SC, Singal AG. Depression and Anxiety Are Common Among Patients With Cirrhosis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31154-X. [PMID: 32835845 DOI: 10.1016/j.cgh.2020.08.045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
208 Saberifiroozi M. Improving Quality of Care in Patients with Liver Cirrhosis. Middle East J Dig Dis 2017;9:189-200. [PMID: 29255576 DOI: 10.15171/mejdd.2017.73] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
209 Lavekar A, Raje D, Sadar A, Manohar T, Manjari KS, Satyanarayana PT. Predictors of Three-month Hospital Readmissions and Mortality in Patients with Cirrhosis of Liver. Euroasian J Hepatogastroenterol 2019;9:71-7. [PMID: 32117694 DOI: 10.5005/jp-journals-10018-1302] [Reference Citation Analysis]
210 Yoder L, Mladenovic A, Pike F, Vuppalanchi R, Hanson H, Corbito L, Desai AP, Chalasani N, Orman ES. Attendance at a Transitional Liver Clinic May Be Associated with Reduced Readmissions for Patients with Liver Disease. Am J Med 2021:S0002-9343(21)00647-1. [PMID: 34655539 DOI: 10.1016/j.amjmed.2021.09.016] [Reference Citation Analysis]
211 Peeraphatdit TB, Kamath PS, Karpyak VM, Davis B, Desai V, Liangpunsakul S, Sanyal A, Chalasani N, Shah VH, Simonetto DA. Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2020;18:477-485.e5. [PMID: 31042580 DOI: 10.1016/j.cgh.2019.04.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
212 Barber T, Toon L, Tandon P, Green LA. Eliciting and Understanding Primary Care and Specialist Mental Models of Cirrhosis Care: A Cognitive Task Analysis Study. Can J Gastroenterol Hepatol 2021;2021:5582297. [PMID: 34222136 DOI: 10.1155/2021/5582297] [Reference Citation Analysis]
213 Figueiredo A, Romero-Bermejo F, Perdigoto R, Marcelino P. The end-organ impairment in liver cirrhosis: appointments for critical care. Crit Care Res Pract. 2012;2012:539412. [PMID: 22666568 DOI: 10.1155/2012/539412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
214 Han B, Wang J, Yang W, Chen X, Wang H, Chen J, Zhang C, Sun J, Wei X. Hydrothermal synthesis of flower-like In2O3 as a chemiresistive isoprene sensor for breath analysis. Sensors and Actuators B: Chemical 2020;309:127788. [DOI: 10.1016/j.snb.2020.127788] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 8.5] [Reference Citation Analysis]
215 Plunkett A, Mortimore M, Good P. Palliative care in cirrhosis with decompensation. Intern Med J 2019;49:904-8. [DOI: 10.1111/imj.14348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
216 Carpentier S, Bhat M, Deschenes M, Wong P, Ghali P, Sebastiani G. A care coordination program to optimize management of cirrhosis: real-life applicability and feasibility in the context of the Canadian health care system. Can J Gastroenterol Hepatol 2014;28:221-2. [PMID: 24729998 DOI: 10.1155/2014/726409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
217 Bodek D, Patel P, Ahlawat S, Orosz E, Nasereddin T, Pyrsopoulos N. Superior Performance of Teaching and Transplant Hospitals in the Management of Hepatic Encephalopathy from 2007 to 2014. J Clin Transl Hepatol 2018;6:362-71. [PMID: 30637212 DOI: 10.14218/JCTH.2017.00078] [Reference Citation Analysis]
218 Bajaj JS. The Three Villages of Hepatic Encephalopathy. Am J Gastroenterol 2021;116:1184-6. [PMID: 33661145 DOI: 10.14309/ajg.0000000000001212] [Reference Citation Analysis]
219 Kanwal F, Tansel A, Kramer JR, Feng H, Asch SM, El-Serag HB. Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013. Am J Gastroenterol. 2017;112:1287-1297. [PMID: 28607480 DOI: 10.1038/ajg.2017.175] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
220 Jesudian A, Barraza L, Steel P, Shen N, Schneider Y, Bodnar D, Farmer B, Dargar S, Del Toro C, Sharma R, Brown RS Jr, Lee JI. Quality improvement initiative increases total paracentesis and early paracentesis rates in hospitalised cirrhotics with ascites. Frontline Gastroenterol 2020;11:22-7. [PMID: 31885836 DOI: 10.1136/flgastro-2019-101199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
221 Tapper EB, Risech-Neyman Y, Sengupta N. Psychoactive Medications Increase the Risk of Falls and Fall-related Injuries in Hospitalized Patients With Cirrhosis. Clin Gastroenterol Hepatol 2015;13:1670-5. [PMID: 25818078 DOI: 10.1016/j.cgh.2015.03.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
222 Liu R, Kang JD, Sartor RB, Sikaroodi M, Fagan A, Gavis EA, Zhou H, Hylemon PB, Herzog JW, Li X, Lippman RH, Gonzalez-Maeso J, Wade JB, Ghosh S, Gurley E, Gillevet PM, Bajaj JS. Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant. Hepatology 2020;71:611-26. [PMID: 31220352 DOI: 10.1002/hep.30827] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
223 Gonzalez JJ, DiBattista J, Gomez V, Gonzalez E, Zhang Q, Vaughn VM, Tapper EB. Impact of Inpatient Attending Specialty and Gastroenterology Consultation on Quality of Care of Patients Hospitalized with Decompensated Cirrhosis. Am J Med 2021:S0002-9343(21)00366-1. [PMID: 34144013 DOI: 10.1016/j.amjmed.2021.05.010] [Reference Citation Analysis]
224 Tandon P, Tangri N, Thomas L, Zenith L, Shaikh T, Carbonneau M, Ma M, Bailey RJ, Jayakumar S, Burak KW, Abraldes JG, Brisebois A, Ferguson T, Majumdar SR. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale. Am J Gastroenterol 2016;111:1759-67. [PMID: 27481305 DOI: 10.1038/ajg.2016.303] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 14.5] [Reference Citation Analysis]
225 Han B, Wang H, Huang H, Liu T, Wu G, Wang J. Micro-fabricated packed metal gas preconcentrator for enhanced monitoring of ultralow concentration of isoprene. J Chromatogr A 2018;1572:27-36. [PMID: 30195860 DOI: 10.1016/j.chroma.2018.08.058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
226 Sempokuya T, Zhang G, Nakagawa K. Temporal trends of cirrhosis associated conditions. World J Hepatol 2019; 11(1): 74-85 [PMID: 30705720 DOI: 10.4254/wjh.v11.i1.74] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
227 Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Chang M, Lai M. A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016;14:753-759. [PMID: 26407750 DOI: 10.1016/j.cgh.2015.08.041] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 11.7] [Reference Citation Analysis]
228 Iliaz R, Ozpolat T, Baran B, Demir K, Kaymakoglu S, Besisik F, Akyuz F. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers. Eur J Gastroenterol Hepatol 2018;30:786-91. [PMID: 29521663 DOI: 10.1097/MEG.0000000000001111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
229 Etxeberria-Lekuona D, Casas Fernández de Tejerina JM, Méndez López I, Oteiza Olaso J, Arteaga Mazuelas M, Jarne Betran V. Multiple hospitalizations at the Department of Internal Medicine of a tertiary hospital. Rev Clin Esp. 2015;215:9-17. [PMID: 25278435 DOI: 10.1016/j.rce.2014.08.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
230 Rosenblatt R, Yeh J, Gaglio PJ. Long-Term Management: Modern Measures to Prevent Readmission in Patients with Hepatic Encephalopathy. Clin Liver Dis 2020;24:277-90. [PMID: 32245533 DOI: 10.1016/j.cld.2020.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
231 Okafor PN, Nnadi AK, Okoli O, Huang AE, Nwaiwu O. Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge. Am J Gastroenterol. 2019;114:464-471. [PMID: 30676364 DOI: 10.14309/ajg.0000000000000050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
232 Wigg AJ, Chinnaratha MA, Wundke R, Volk ML. A chronic disease management model for chronic liver failure: WIGG ET AL. Hepatology 2015;61:725-8. [DOI: 10.1002/hep.27152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
233 Deng LX, Kent DS, O'Riordan DL, Pantilat SZ, Lai JC, Bischoff KE. Symptom Burden Is Associated with Increased Emergency Department Utilization among Patients with Cirrhosis. J Palliat Med 2021. [PMID: 34348042 DOI: 10.1089/jpm.2021.0219] [Reference Citation Analysis]
234 Ho SB, Matheny ME, Schnabl BE. Changes in Hospital Admissions and Mortality for Complications of Cirrhosis: Implications for Clinicians and Health Systems. Gut Liver 2016;10:8-9. [PMID: 26696026 DOI: 10.5009/gnl15593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
235 Nathwani R, Mukherjee S, Forlano R, Mullish BH, Vergis N, Selvapatt N, Manousou P, Nayagam S, Lemoine M, Dhar A. Letter: liver disease and COVID-19-not the perfect storm. Aliment Pharmacol Ther 2020;52:572-4. [PMID: 32656833 DOI: 10.1111/apt.15872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
236 Shouval D. Focus. J Hepatol 2013;59:201-2. [PMID: 23707442 DOI: 10.1016/j.jhep.2013.05.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
237 Bajaj JS, O'Leary JG, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, Maliakkal B, Biggins SW, Thuluvath PJ, Fallon MB, Subramanian RM, Vargas HE, Lai J, Thacker LR, Reddy KR. Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures. Clin Gastroenterol Hepatol 2017; 15: 565-574. e4. [PMID: 27720916 DOI: 10.1016/j.cgh.2016.09.157] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
238 Tandon P, Reddy KR, O'Leary JG, Garcia-Tsao G, Abraldes JG, Wong F, Biggins SW, Maliakkal B, Fallon MB, Subramanian RM, Thuluvath P, Kamath PS, Thacker LR, Bajaj JS; North American Consortium for the Study of End-Stage Liver Disease. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology 2017;65:217-24. [PMID: 27775842 DOI: 10.1002/hep.28900] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
239 Ghaoui R, Friderici J, Desilets DJ, Lagu T, Visintainer P, Belo A, Sotelo J, Lindenauer PK. Outcomes associated with a mandatory gastroenterology consultation to improve the quality of care of patients hospitalized with decompensated cirrhosis. J Hosp Med 2015;10:236-41. [PMID: 25557938 DOI: 10.1002/jhm.2314] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
240 Suraweera D, Sundaram V, Saab S. Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions. Gut Liver. 2016;10:509-519. [PMID: 27377741 DOI: 10.5009/gnl15419] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
241 Schmidt ML, Barritt AS, Orman ES, Hayashi PH. Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology. 2015;148:967-977.e2. [PMID: 25623044 DOI: 10.1053/j.gastro.2015.01.032] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 11.6] [Reference Citation Analysis]
242 Bloom P, Wang T, Marx M, Tagerman M, Green B, Arvind A, Ha J, Bloom J, Richter JM. A Smartphone App to Manage Cirrhotic Ascites Among Outpatients: Feasibility Study. JMIR Med Inform 2020;8:e17770. [PMID: 32876581 DOI: 10.2196/17770] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
243 Kruger AJ, Aberra F, Black SM, Hinton A, Hanje J, Conteh LF, Michaels AJ, Krishna SG, Mumtaz K. A validated risk model for prediction of early readmission in patients with hepatic encephalopathy. Annals of Hepatology 2019;18:310-7. [DOI: 10.1016/j.aohep.2018.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
244 Hayward KL, Valery PC, Martin JH, Karmakar A, Patel PJ, Horsfall LU, Tallis CJ, Stuart KA, Wright PL, Smith DD, Irvine KM, Powell EE, Cottrell WN. Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis. World J Gastroenterol 2017; 23(40): 7321-7331 [PMID: 29142479 DOI: 10.3748/wjg.v23.i40.7321] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
245 Gaspar R, Rodrigues S, Silva M, Costa-Moreira P, Morais R, Andrade P, Cardoso H, Albuquerque A, Liberal R, Macedo G. Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis. Dig Liver Dis 2019;51:1423-9. [PMID: 31113738 DOI: 10.1016/j.dld.2019.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
246 Sobotka LA, Spitzer C, Hinton A, Michaels A, Hanje AJ, Mumtaz K, Conteh LF. Management of hepatic hydrothorax and effect on length of stay, mortality, cost, and 30-day hospital readmission. J Gastroenterol Hepatol 2020;35:641-7. [PMID: 31441096 DOI: 10.1111/jgh.14842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Kanwal F, Tapper EB, Ho C, Asrani SK, Ovchinsky N, Poterucha J, Flores A, Ankoma-Sey V, Luxon B, Volk M. Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2019;69:1787-1797. [PMID: 30586188 DOI: 10.1002/hep.30489] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
248 Kimbell B, Murray SA, Byrne H, Baird A, Hayes PC, MacGilchrist A, Finucane A, Brookes Young P, O'Carroll RE, Weir CJ, Kendall M, Boyd K. Palliative care for people with advanced liver disease: A feasibility trial of a supportive care liver nurse specialist. Palliat Med 2018;32:919-29. [PMID: 29516776 DOI: 10.1177/0269216318760441] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
249 Hillert A, Schultalbers M, Tergast TL, Vonberg RP, Rademacher J, Wedemeyer H, Cornberg M, Ziesing S, Maasoumy B, Höner Zu Siederdissen C. Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany. BMC Gastroenterol 2021;21:296. [PMID: 34284732 DOI: 10.1186/s12876-021-01871-w] [Reference Citation Analysis]
250 Barsuk JH, Cohen ER, Feinglass J, McGaghie WC, Wayne DB. Clinical outcomes after bedside and interventional radiology paracentesis procedures. Am J Med 2013;126:349-56. [PMID: 23398950 DOI: 10.1016/j.amjmed.2012.09.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
251 Dai J, Zhao J, Du Y, McNeil EB, Chongsuvivatwong V. Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients. Ther Clin Risk Manag 2019;15:979-89. [PMID: 31496713 DOI: 10.2147/TCRM.S203883] [Reference Citation Analysis]